Operating across the full spectrum of innovation

We’re a different kind of global biopharmaceutical company.

Neurological Conditions Take So Much: Teva is Working to Give Something Back

Teva has been committed to supporting people with neurological conditions for over 30 years. Hear about the latest innovative advancements from our global medical experts.

Discover more

What to Know About Schizophrenia

A guide to Schizophrenia: a serious, long-term mental disorder that profoundly impacts how a person thinks, feels, and behaves.

Discover more

Press Releases

May 22, 2025

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

May 20, 2025

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

May 20, 2025

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

May 19, 2025

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

May 19, 2025

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031

May 15, 2025

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

May 12, 2025

Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

May 7, 2025

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

May 7, 2025

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

May 5, 2025

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Healthy Future: Sustainability at Teva

Teva scientists in Sydney, Australia working in the lab

Teva's Healthy Future Report: Creating the Future We Want to See

Our latest Healthy Future Report shows the steps Teva is taking for the health of people, the planet and our business.

View the report now

Take a closer look at what we do

Spreading HOPE: How Teva is improving access to medicines across the globe

Eric Hughes, Chief Medical Officer giving a speech

How Can We Use AI to Make Medicines More Efficiently?

Discover more

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Discover more

What to know about schizophrenia

Discover more

Complex Generics: Facts, Figures and Who They Benefit

Tools & Resources for Caregivers

Discover more

People discussing why diversity in clinical trials is important

Why Diversity in Clinical Trials is So Important

Discover more

Careers at Teva

Four lab-coated professionals share ideas, emphasizing Teva's commitment to improving health daily.

Make a difference to people's health, every day

Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves

Explore a Teva Career